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SUMMARY 
  
Edible bird’s nest (EBN) is an emergent industry in Malaysia. In 2016, EBN worth RM 1.2 billion with the total 
production of 228-tonne metrics. EBN is salivary secretion of swiftlets (Aerodramus spp.) that contained various 
nutritive values. Back in Tang Dynasty, it had been recognized as a natural product with broad medicinal effects. 
Recently, various scientific studies have been done to elucidate the medicinal properties of this precious food. For the 
past 10 years, antiviral effects of EBN had been explained via in-vitro and in-vivo well-designed researches, in which 
generally EBN is exerting a good alternative food for prophylactic and therapeutic agent against Influenza A virus 
infection in the laboratory setting. The limited study had been done to identify the bioactive ingredient of EBN that 
have antiviral properties. Nevertheless, based on the previous nutritional studies, some contents of EBN have been 
hypothesised to serve as an antiviral agent, and comprehensive study is required to explicate those claimed.  The aim of 
this paper is to review on the recent discovery pertaining to the potential antiviral effect of EBN in the cell culture and 
animal model studies. 
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INTRODUCTION 
 
Edible bird’s nest (EBN) production is an emerging 
industry in Malaysia. This industry is worth RM 1.2 
billion in 2016 with 105 tan metrics of EBN was exported 
last year. There are two types of EBN have been produced 
locally, namely white and black (red) EBN(Isa, 2016). 
Due to nutritional content, quality and demand, white 
EBN is the most common type of EBN been produced and 
marketed in Malaysia (Looi and Omar, 2016). This 
industry is supported by Department of Veterinary 
Services (DVS) and parallel with government campaign in 
promoting EBN soup, instead of shark fin soup in 5-star 
hotels and restaurants (Isa, 2016). Currently, this industry 
is expanding dramatically due to high market demand 
from the local and international consumers (Ma and Liu, 
2012b). Therefore, the EBN collectors started to create a 
swiftlet housing for man-made EBN, instead of natural 
EBN from the cave, in the paddy and oil palm plantation. 
As a result, in 2016 the EBN production had been met the 
local market demand and projected the surplus to be 
exported to international markets such as Middle East, 
Europe and even the Republic of China. This remarkable 
growth has made Malaysia as a second largest EBN 
producer country in the world, behind our neighbour 
Indonesia with the total production of 228-tonne metrics 
in 2016 (Isa, 2016). 
The history of this natural product was documented 
ever since Tang Dynasty (618-907 CE) and frequently 
consumed by Chinese royal family. Due to their extensive 
medicinal properties and well-being effects (Marcone, 
2005). In general, EBN is mainly composed by 
glycoprotein conjugated such as sialic acid, glucosamine  
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and galactosamine (Ma and Liu, 2012b). Besides that, it 
also contained minerals, vitamins and some hormones 
(Yu-Qin et al., 2000; Ma and Liu, 2012a). This product 
which derived from the secretion of swiftlets’ salivary 
glands is produced all year round, but predominantly 
during the breeding season (between September to 
December). Both sexes are involved in the nest building 
but mainly the nest was built by the male swiftlet (Looi 
and Omar, 2016). EBN composed of polymerised salivary 
secretion with varies the degree of feather and plumage 
composition that will support the nestling and mothers for 
up to 40 days (Langham, 1980; Ma and Liu, 2012b). In 
general, swiftlets (Aerodramus fuciphagus) is an aerial 
insectivore that mainly inhabits in limestone cave situated 
at more than 1300 meters above the sea level to avoid 
interspecies competition (Lim et al., 2002). This amazing 
bird is anatomically different from another common swift. 
They have shorter metatarsal bones and digits together 
with underdeveloped (smaller and thinner) caudoproximal 
of pelvic muscles bundle (biceps femoris, semitendinosus, 
semimembranosus and gastrocnemius), resulting inability 
of the swiftlet to perch, walk and stand (Zuki et al., 2012). 
In the past decade, several proteomic and metabolic 
studies have been documented in discovering the 
bioactive ingredient of EBN, using various modalities and 
technique (Chua et al., 2014a; Chua et al., 2014b; Zulkefli 
et al., 2017). Most of the protein of interest are formed in 
a glycoconjugate sequences with smaller protein size 
ranged between 37-52 kDa (Zulkefli et al., 2017), 
compared to China (106-128 kDa) (Liu et al., 2012) and 
Indonesia (95.5 kDa) (Utomo et al., 2014). Among the 
highlighted proteins that play important role in preventing 
infectious agent is acidic chitinase precursor, which 
involved in protective mechanism against nematodes, 
fungi and several pathogens (Zulkefli et al., 2017). 
Besides that, anti-fungicidal such as 3-phenyl-5-ureido-1, 
2, 4-trizole and heptadecasphinganine have been 
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detected in the EBN (Chua et al., 2014a), and this finding 
is in concordance with claimed described by Ma and Liu 
(2012). Thymol-β-D-glucopyranoside was also detected 
via gas-chromatography mass-spectrometry (GC-MS), 
which is effective against food-borne microorganism 
(Staphylococcus aureus and Escherichia coli) (Chua et 
al., 2014a). However, up to this point, there is limited 
study pertaining to the bioactive ingredient that plays a 
pivotal role in antiviral properties. Hence, in the past two 
years, several studies have been conducted to explain the 
possible antiviral effect of the EBN in cell culture and 
animal model. Thus, in this article, substantial review 
pertaining antiviral properties and the effects towards 
Influenza virus will be discussed.  
 
Pandemic Influenza A Virus 
 
There are three subtypes of influenza virus, namely 
A, B and C. Among those three, only type A is the most 
common causing pandemic outbreaks. Influenza virus is a 
family member of Orthomyxoviridae, containing eight 
single-stranded, negative sense, RNA genome in a viral 
envelope, coated with two major nucleoprotein 
hemagglutinin (HA) and neuraminidase (NA) (Noda, 
2012). The HA and NA are important glycoproteins for 
fusion of the virus inside the host cell, and release of the 
new virions from the infected cell, respectively (Ni et al., 
2014; Gong et al., 2007). These two surface proteins can 
be classified into 16 and 9 subtypes accordingly; shifting 
and drifting of these proteins will lead to the pandemic 
outbreak of influenza A virus worldwide (Rambaut et al., 
2008). This seasonal influenza virus causing death 250, 
000-500, 000 people annually with the severe illness 
about 3-5 million worldwide (Rotrosen and Neuzil, 2017). 
Therefore, it is a worldwide importance disease for the 
medical and veterinary field. 
The recent epidemic of H1N1 in Malaysia was 
documented back in June 2017 at Perak and Ministry of 
Health Malaysia had been released a statement that 
Malaysia is free from this disease for this time being. 
Unfortunately, this disease is highly infectious, contagious 
and zoonotic. High mortality and culling rate recorded in 
animals particularly in the epidemic area was causing a 
detrimental impact on the farmers and indirectly been 
compromising food security for human consumption. In a 
recent re-emerging H1N1 pandemic outbreak (2009) had 
caused negative impacts to the farmer which directly 
linked to the involvement of veterinarian in culling to 
prevent the disease to spread (Beigent and McCauley, 
2003). In fact, domestic pig (Sus scrofa) was recognised 
as the mixing vessels to produce a virulent type of 
influenza virus, causing interspecies infection and 
outbreaks; including human (Hab et al., 2011). Therefore, 
this disease is a public health issue which involving 
medical practitioners and veterinarians to play a role in 
preventing the disease to spread. 
  
Prophylactic and Therapeutic Antiviral 
  
Pandemic influenza A virus (IAV) infection was 
tremendously given an impact to the worldwide 
population in term of health and economic perspective 
(Fukuyama and Kawaoka, 2011). Up to this point, there 
are no effective preventive and therapeutic measures were 
documented. Several antivirals have been developed in 
the past few decades, but every single of them possessing 
either weaknesses or benefits (Mehrbod et al., 2014). All 
the antiviral that available in the market is primarily 
struggling to contain this virus via inhibition of their 
molecular viral replication (Haghani et al., 2017). The 
dynamic mechanism of cell infection started with the 
attachment of viral hemagglutinin (HA) protein-bounded 
lipid envelope with N-acetylneuraminic acid (sialic acid)-
receptor on the plasma membrane of the host cell and 
causing internalization of viral particles by receptor-
mediated macropinocytosis. Followed with trafficking the 
endosomes to the perinuclear region and initiating 
endosomal membrane fusion, and finally releasing viral 
ribonucleoprotein complex (vRNP) in the cytosol, before 
transported into the host nucleus for replication (Edinger 
et al., 2014). At the same time, influenza virus had started 
to regulate lysosomes fusion with auto phagosomes, 
which will accelerate the virus replication, reduce 
antigenicity of the infected cell and manipulate the 
process of apoptosis (Zhang et al., 2014). In the recent 
studies, EBN has been demonstrated scientifically to act 
as prophylaxis and potential therapeutic agent in 
managing influenza infection (Hanghani et al., 2017). 
This statement is reinforced by the in-vitro and in-
vivo study in the past two years as will be discussed in the 
following paragraphs. 
In a simple hemagglutination assay, EBN able to 
inhibit erythrocytes hemagglutination, indicating a direct 
interaction between EBN and influenza virus in a dose-
dependent manner (Hanghani et al., 2017). By contrast, a 
recent natural-derived antiviral was unable to inhibit IAV 
in hemagglutination assay as what been observed in the 
EBN (Shi et al., 2017). On the other hand, the virus titter 
in the EBN treated cell showed significant reduction while 
increasing the cell viability in a post-viral inoculation. 
Besides that, EBN-treated cell was showing significant 
antiviral activity by reducing virus titre from 1:128 to 
1:10-1:20 with 61% of protection (Haghani et al., 2017), 
compared to phenanthrenes of Blettila striata which can 
provide protection ranged between 21-76% (Shi et al., 
2017). Rab5 and RhoA are the early markers for the viral 
entry that has been expressed in the development of 
endosome in EBN treated cell was showing significant 
protein suppression of these Rab5 and RhoA proteins 
(Hanghani et al., 2017). As the autophagosomes are 
accelerating virus replication via serving as the anabolic 
pool (Zhirnov and Klenk, 2013), the protein marker for 
autophagosomes development (LC3-II) supposedly high 
in the infected cell, but in cell treated with EBN that 
protein expression was reduced significantly, indicating 
antiviral properties of the EBN. Interestingly, EBN 
demonstrated cellular shapes normalization and actin 
filament reorientation upon immunoblotting staining. On 
the other hand, upon the viral entry, lysosomes only 
mildly induce due to their inhibition of the virus, when 
cell treated with EBN, lysosomes densities were increased 
when stained with immunofluorescence. In a brief 
conclusion, the authors suggested the pharmacodynamic 
of EBN in treating IAV infection is could be from early 
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endosome stimulation and amelioration of lysosomes 
degradation (Hanghani et al., 2017). In the other paper 
from the same authors, via in vitro study, EBN was 
suggested to have an antiviral effect via preventing of the 
virion from the infected cell and contained it in the 
cytosol. In addition, the authors showed the EBNwas 
demonstrating cytokines tumour necrosis factor-α (TNF-
α) and nuclear factor kappa-light-chain-enhancer of 
activated B cells (NFκB) up-regulation significant 
(Haghani et al., 2016). TNF-α is important for viral 
replication inhibition, and NFκB is important in cell 
survivability and anti-apoptotic (Swardfager et al., 2010). 
Besides that, EBN-treated cell was down-regulating 
chemokine (C-C motif) ligand 2 (CCL2). This chemokine 
will be exuberated by the influenza virus and causing 
aberrant cytokine production and excessive cell apoptosis 
by induction of tumour necrosis factor-related apoptosis 
inducing legend (TRAIL) (Herold et al., 2008). This 
chemokine has the ability to cause deadly acute 
encephalopathy associated with influenza A virus due to 
excessive immune stimulation (Lee et al., 2010) 
Therefore, reduction of this chemokine is advantageously 
in human that had been infected by influenza virus 
(Aldridge et al., 2009). Simultaneously, interleukin-27 
(IL-27) was also increased in the EBN treated cell and this 
chemokine can balance out the excessive innate 
inflammatory and as anti-pyretic by a synergistically 
production of interleukin-10 (IL-10) (Sun et al., 2014). 
In the in-vivo study, EBN treated mice was 
significantly reduced NA viral copy in the lung. In fact, in 
the pre-treated mice with IAV showed zero viral loads in 
the lung indicating EBN efficiently served a prophylactic 
antiviral. In regard to the immunomodulatory properties, 
EBN treated mice showed amazing immune chemistry 
reaction (Hanghani et al., 2016). Interferon-γ (IFN-γ) was 
the highest cytokines been produced by the EBN treated 
mice and this cytokine is very important for viral 
replication inhibition and major histocompatibility type I 
and II (MHC-I and MHC-II) activation (Haghani et al., 
2016; Lee et al., 2010). Other cytokines that increased 
significantly on the first day post infection was IL-1β 
(initiate immune response), IL-2 (crucial factor for T cell-
dependent IFN-γ), IL-6 (controlling lung damage-induced 
by influenza virus, viral-induced apoptosis and activating 
virus-specific antibody production) and TNF-α (antiviral 
activity, suppress CCL2 and fibrotic growth factor [TGF-
b1]). However, IL-1β, IL2, IL-6 and IL-10 were 
significantly reduced by day 3 post-infection in EBN 
treated mice; in order, to reduce pulmonary inflammation 
and lethal effect of these cytokines (Haghani et al., 2016). 
In fact, the anti-inflammatory and antioxidant properties 
of EBN have been described in other previous studies and 
might be linked to the anti-viral properties of EBN (Aswir 
and Wan Nazaimoon, 2011; Yida et al., 2014; Yida et al., 
2015b). In addition, at day 5 of post-infection, there is no 
viral copy was detected in all mice EBN-treated group 
(Haghani et al., 2016). Significant of IL-2 and IL-10 
reduction by day 10 in the EBN-treated group is important 
because persistence high secretion of these cytokines will 
be an open entry for secondary bacterial pneumococcal 
pneumonia (van der Sluijs et al., 2004). In general, EBN 
able to activate innate immune system since day one, to 
inhibit viral infection and indirectly contain the influenza 
virus pathogenesis (Haghani et al., 2016). Paradoxically, 
in other natural-based antiviral is exerting their antiviral 
properties via inhibition of virus replication (Shi et al., 
2017). 
  
Antiviral Bioactive Ingredient 
 
In overall, EBN potentially can serve as the 
prophylactic and therapeutic antiviral against influenza 
infection by modulating the immune response and 
improve the adverse effect of influenza disease (Haghani 
et al., 2016). Nonetheless, the proteomic and 
metabolomics studies of the EBN should be conducted to 
identify the signature bioactive ingredient that plays the 
major role in antiviral properties. However, the authors 
will discuss the possible bioactive ingredient that might 
serve as antiviral agent. One previous study had described 
that sialic acid is the possible component of EBN that 
have been neutralising the IAV infection (Guo et al., 
2006). Sialic acid (SA) or N-acetylneuraminic acid is a 
major glycoprotein conjugated on the oligosaccharide of 
the EBN (Schauer, 2016). In other two recent studies 
demonstrated the EBN contained 9-11% sialic acid 
(Colombo et al., 2003; Yida et al., 2015a), supported by 
another review paper on sialic acid which mentioned EBN 
is the highest natural product that contained sialic acid 
(Schauer, 2016). Sialic acids on the EBN released from 
the major carbohydrate component via acidic hydrolysis 
of the digestive enzyme (pancreatic enzyme) (Yagi et al., 
2008). In the previous study, Guo and co-researchers 
(2006) have documented the hydrolysed SA is propitious 
for the antiviral (Guo et al., 2006). The major type of SA 
in the EBN is Neu5Ac which composed up to 96.8% with 
O-acetyl sialic acid is the main species of SA (Guo et al., 
2006; Yagi et al., 2008). 
Once a host gets infected with IAV, viral HA protein 
will play its major role in the first contact with host cell 
receptor (Ni et al., 2014). This binding and attachment 
arespecific to the sialic acid (SA)-containing receptor on 
the host cell, to allow internalization of viral-receptor 
complex inside the clathrin-coated endosome (Edinger et 
al., 2014). As the availability of sialic acid abundant in the 
extracellular, this sialic acid will act as a decoy and 
resulting IAV binding, instead of attachment on SA-
containing receptor of the host cell. Hence, reducing the 
incidence of the infected cell with IAV. The previous 
study had shown hydrolysed SAis more potent to act as 
decoy antiviral, plus the smaller size of SA will also give 
more impact as antiviral properties of EBN (Guo et  al., 
2006). 
Other than that, authors also hypothesised the role of 
lactoferrin as a bioactive ingredient in the EBN that help 
in its antiviral properties. Lactoferrin (LF) is a family 
member of transferrin (serum transferrin, 
melanotransferrin and ovotransferrin) and is formed in a 
glycoprotein with single polypeptide chain, weighing 
about 78 kDa (Baker et al., 2000; Lambert et al., 2005). 
There is no study has been done to measure the size of LF 
in the bird particularly swiftlet, but then again the 
structural size of LF in human and bovine milk is 691 and 
696 amino acids (Baker et al., 2000; Moore et al., 1997). 
J. Vet. Malaysia (2017) 29 (2):14-19 
17 
 
Authors believe the size of swiftlet’s LF should be around 
that range, as the LF is a body biological fluid that had 
been secreted in the milk, saliva and seminal fluid (Cheng 
et al., 2008); EBN is a polymerised saliva secretion. LF 
ubiquitously present in human and bovine milk with 
concentration up to 3.00 and 0.49 g/L respectively (Artym 
and Zimecki, 2005). In EBN, the LF has contained about 
4.68 µg/mg with a combination of another transferrin 
family such as ovotransferrin (10.23 µg/mg) (Hou et al., 
2015). Instead of antiviral properties, LF also serves as 
antibacterial, antifungal, anti-inflammatory and anti-
carcinogen (Wang et al., 2017). In the previous study, LF 
is might protect the host cell tropism in the early stage of 
infection, but later they claimed LF might prevent the 
virus replication after infection of the host cell (Beljaars et 
al., 2004; Ikeda et al., 2000). LF is effective against both 
enveloped and non-enveloped virus (Lin et al., 2002; 
Seganti et al., 2004). In pharmacodynamics wise, a 
worldwide accepted hypothesis suggested the LF will bind 
and block the glycosaminoglycans (GAG) viral receptor 
specifically heparan sulphate. Thus, averting the first 
contact of viral protein with cell tropism receptor of the 
host and preventing cell infection (Gonzalez-Chavez et 
al., 2009). In a recent study, bovine LF was incorporated 
in the H1N1 vaccine to stimulate the production of 
antibody against IAV (Sherman et al., 2015). The other 
proposed mechanism of LF in exerting antiviral properties 
is by iron transferring (Voswinkel et al., 2016). LF 
induced and promoted absorption of iron in the body 
(Paesano et al., 2010). The iron will be released in the 
GIT for absorption after been acidified in the gastric juice, 
as the iron will be released up to 40% from the initial 
structure (Rastogi et al., 2016). In a recent in-vitro and in-
vivo study had demonstrated high concentration of iron 
been absorbed will inhibit IAV growth and replication 
(Kumar et al., 2016). Therefore, LF is another potential 
bioactive component that should be considered as a 
metabolite that served as an antiviral effect in EBN. 
 
CONCLUSION 
 
Re-emerging of the pandemic IAV particularly 
Highly-Pathogenic Avian Influenza (HPAI) had drawn 
attention to the world population. As this disease is 
infectious, contagious and zoonotic, medical officer and 
the veterinarian must have a strong networking in 
preventing the outbreak and spreading of this disease. 
Even though, the existence of prophylactic and 
therapeutic agents in the market, the effectiveness of those 
measures is persistence doubtable. Therefore, a more 
extensive study must be conducted to give a sight for 
better treatment. Long-term consumption of chemically 
derived drugs is believed to give the side effects on the 
health status. Thus, the emerging of nutraceutical industry 
will give a new sight for prevention and treatment in 
future via a holistic, safe and effective approach. EBN is 
one of the precious Chinese food that is believed to give a 
well-being effect in many aspects since thousands of years 
ago. The authors believed the more recent study will be 
published to enlighten world population on the benefits of 
EBN. Validation of bioactive ingredient is another 
prospect that should be considered when claiming the 
beneficial effect of EBN or other natural product. 
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